Estimates Revisions Faron Pharmaceuticals Oy
Stocks
FARN
FI4000153309
Biotechnology & Medical Research
|
Market Closed -
London S.E.
19:35:02 28/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 39.00 GBX | +12.39% |
|
+11.43% | -78.33% |
| 08-27 | Faron Pharmaceuticals Announces First Patient Enrolled in BEXAR Investigator-Initiated Trial | CI |
| 08-26 | EARNINGS and TRADING: Empresaria ups guidance as cost cuts bear fruit | AN |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- FARN Stock
- Consensus Faron Pharmaceuticals Oy
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
